Migalastat for the treatment of Fabry disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Migalastat for the treatment of Fabry disease

Published:2018-05-04 Issue:5 Volume:6 Page:301-309
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Sunder-Plassmann Gere¹,Schiffmann Raphael²,Nicholls Kathleen³

Affiliation:

1. Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna, Vienna, Austria

2. Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX, USA

3. Royal Melbourne Hospital, University of Melbourne, Parkville, Australia

Funder

Amicus Therapeutics

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2018.1469978

Reference39 articles.

1. Fabry disease

2. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

3. High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

4. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sortilin inhibition treats multiple neurodegenerative lysosomal storage disorders;2023-09-22

2. Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-12-01

3. A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE);Journal of Enzyme Inhibition and Medicinal Chemistry;2022-09-06

4. Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency;Current Medicinal Chemistry;2022-01

5. Tacrine-sugar mimetic conjugates as enhanced cholinesterase inhibitors;Organic & Biomolecular Chemistry;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3